Literature DB >> 30914233

Prevalence of Pre-Pregnancy Diabetes, Obesity, and Hypertension in Canada.

Howard Berger1, Nir Melamed2, Beth Murray-Davis3, Haroon Hasan4, Karizma Mawjee5, Jon Barrett3, Sarah D McDonald6, Michael Geary7, Joel G Ray8.   

Abstract

OBJECTIVE: Pre-existing diabetes mellitus (D), obesity (O), and chronic hypertension (H) can each alter the natural course of pregnancy, especially when they cluster together. Because the prevalence of various combinations of D, O, and H is unknown, the current study was undertaken.
METHODS: This population-based cross-sectional study included 506 483 singleton and twin live birth and stillbirth deliveries in Ontario, occurring at ≥20 weeks gestation. All hospital births from 2012 to 2016 were identified in the Better Outcomes Registry and Network information system. The prevalence per 1000 births (95% confidence interval [CI]) of D, O, and H and their combinations were calculated. Prevalence estimates were stratified by twin and singleton gestations, maternal age, parity, and ethnicity (Canadian Task Force Classification II-2).
RESULTS: During the study period, 5493 women (10.8 per 1000 births; 95% CI 10.6-11.1) had D, 90,177 (178.2; 95% CI 177.0-179.3) had O, and 5667 (11.2; 95% CI 10.9-11.5) had H. The prevalence per 1000 of DO was 4.8, DH 1.0, and OH 5.5, whereas 359 women (0.71 per 1000) had all three. D and H each linearly increased with rising maternal age, along with their combinations, and to some degree with higher parity. The combination of O and H was highest among women of Black ancestry (14.5 per 1000) and lowest among those of Asian ancestry (3.0 per 1000).
CONCLUSION: D, O, and H are common conditions in pregnancy, both alone and in various combinations. These data can be used to assess the impact of each state on perinatal health.
Copyright © 2019 The Society of Obstetricians and Gynaecologists of Canada/La Société des obstétriciens et gynécologues du Canada. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Diabetes mellitus; chronic hypertension; obesity; pre-pregnancy; pregnancy; prevalence; risk

Year:  2019        PMID: 30914233     DOI: 10.1016/j.jogc.2019.01.020

Source DB:  PubMed          Journal:  J Obstet Gynaecol Can        ISSN: 1701-2163


  6 in total

1.  Aspirin Use for Preeclampsia Prevention Among Women With Prepregnancy Diabetes, Obesity, and Hypertension.

Authors:  Joel G Ray; Kasim E Abdulaziz; Howard Berger
Journal:  JAMA       Date:  2022-01-25       Impact factor: 157.335

2.  Risk of severe maternal morbidity or death in relation to elevated hemoglobin A1c preconception, and in early pregnancy: A population-based cohort study.

Authors:  Alexander J F Davidson; Alison L Park; Howard Berger; Kazuyoshi Aoyama; Ziv Harel; Jocelynn L Cook; Joel G Ray
Journal:  PLoS Med       Date:  2020-05-19       Impact factor: 11.069

3.  Maternal Body Mass Index Is Associated with Profile Variation in Circulating MicroRNAs at First Trimester of Pregnancy.

Authors:  Kathrine Thibeault; Cécilia Légaré; Véronique Desgagné; Frédérique White; Andrée-Anne Clément; Michelle S Scott; Pierre-Étienne Jacques; Renée Guérin; Patrice Perron; Marie-France Hivert; Luigi Bouchard
Journal:  Biomedicines       Date:  2022-07-18

4.  Impact of diabetes, obesity and hypertension on preterm birth: Population-based study.

Authors:  Howard Berger; Nir Melamed; Beth Murray Davis; Haroon Hasan; Karizma Mawjee; Jon Barrett; Sarah D McDonald; Michael Geary; Joel G Ray
Journal:  PLoS One       Date:  2020-03-25       Impact factor: 3.240

5.  Association between gestational weight gain and severe adverse birth outcomes in Washington State, US: A population-based retrospective cohort study, 2004-2013.

Authors:  U Vivian Ukah; Hamideh Bayrampour; Yasser Sabr; Neda Razaz; Wee-Shian Chan; Kenneth I Lim; Sarka Lisonkova
Journal:  PLoS Med       Date:  2019-12-30       Impact factor: 11.069

6.  Data Resource Profile: Better Outcomes Registry & Network (BORN) Ontario.

Authors:  Malia S Q Murphy; Deshayne B Fell; Ann E Sprague; Daniel J Corsi; Shelley Dougan; Sandra I Dunn; Vivian Holmberg; Tianhua Huang; Moya Johnson; Michael Kotuba; Lise Bisnaire; Pranesh Chakraborty; Susan Richardson; Mari Teitelbaum; Mark C Walker
Journal:  Int J Epidemiol       Date:  2021-11-10       Impact factor: 7.196

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.